From pharmaceuticals to alternative treatments for HIV/AIDS: what is the potential?
The current approach for dealing with the global AIDS pandemic focuses on technology, particularly pharmaceuticals. However, most of the world's PLWHA (people living with HIV/AIDS) have little or no access to these expensive treatments. Additionally, such technologies have not proven themselves adequate in addressing AIDS in global terms. When the health of communities is prioritized, rather than the interests of pharmaceutical companies and biomedicine, alternative strategies and policies can be considered. These strategies include seriously investigating traditional medicines in other cultures, rather than adopting an uncritical assumption that the biomedical approach is preferable. The limited research available suggests that some alternative treatments could indeed turn out to be useful in treating HIV/AIDS. However, without Western support for rigorous evaluation and development of local alternative therapies, the potential of these treatments for HIV/AIDS will continue to be dismissed. Additionally, the rights of communities to self-determination, and PLWHA to the best possible primary health care, whether in rich or poorer nations, will also be diminished.
Ridge
D
D
School of Public Health, La Trobe University, Bundoora, Victoria, Australia.
Arachne
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000628:therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001315:Australia; D000529:Complementary Therapies; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy / Q000628:therapy*; D006801:Humans